Hwan Mook Kim
Overview
Explore the profile of Hwan Mook Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
2580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeong K, Park S, Park M, Kim H
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686097
Src is emerging as a promising target in triple-negative breast cancer (TNBC) treatment because it activates survival signaling linked to the epidermal growth factor receptor. In this study, the effect...
2.
Jeong K, Sim J, Park M, Kim H
World J Gastroenterol
. 2022 Sep;
28(27):3422-3434.
PMID: 36158271
Background: The biochemical phenomenon defined as poly adenosine diphosphate (ADP)-ribosylation (PARylation) is essential for the progression of pancreatic cancer. However, the excessive accumulation of poly ADP-ribose (PAR) induces apoptosis-inducing factor...
3.
Jeong K, Sim J, Park M, Kim H
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33806179
Hypoxic cancer cells meet their growing energy requirements by upregulating glycolysis, resulting in increased glucose consumption and lactate production. Herein, we used a unique approach to change in anaerobic glycolysis...
4.
Mishra S, Bae Y, Lee Y, Kim J, Oh S, Kim H
Front Cell Dev Biol
. 2021 Feb;
8:571676.
PMID: 33585438
Chemosensitization of cancer cells with small molecules may improve the therapeutic index of antitumoral agents by making tumor cells sensitive to the drug regimen and thus overcome the treatment resistance...
5.
Jeong K, Park M, Sim J, Kim H
Molecules
. 2020 Nov;
25(22).
PMID: 33202899
Sorafenib has been recently used for the treatment of patients with advanced colorectal cancer (CRC) and is recognized for its therapeutic value. However, the continuous use of sorafenib may cause...
6.
Park S, Lee J, Park M, Jeong K, Kim H
Anticancer Res
. 2020 Apr;
40(4):1989-1996.
PMID: 32234888
Background/aim: The antitumor effect of sustained calcium supply on Src degradation was investigated in the context of hormone-dependent breast cancer, followed by elucidation of the underlying mechanisms. Materials And Methods:...
7.
Sung I, Park S, Jeong K, Kim H
Life Sci
. 2019 Aug;
233:116727.
PMID: 31381895
Aims: Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in elderly people. The pathogenesis of neovascular AMD is known but is closely related to inflammation and choroidal...
8.
Sim J, Park M, Baek J, Lee H, Jeong K, Kim H
Anticancer Res
. 2018 Aug;
38(8):4667-4676.
PMID: 30061234
Background/aim: Capecitabine is a pro-drug of 5-fluorouracil (5-FU), and is an orally available chemotherapeutic used to treat colorectal cancer (CRC). Recently, research has focused on improving its efficacy at lower...
9.
Jeong K, Kim E, Park M, Kim H
Diagnostics (Basel)
. 2018 Apr;
8(2).
PMID: 29641512
Various methods are available for cancer screening, and the methods are performed depending on the origin site of cancer. Among these methods, biopsy followed by medical imaging is the most...
10.
Kim I, Sung I, Sim J, Park M, Jeong K, Kim H
Int J Mol Sci
. 2018 Apr;
19(4).
PMID: 29641465
Despite the development of numerous therapeutics targeting the epithelial growth factor receptor (EGFR) for non-small cell lung carcinoma (NSCLC), the application of these drugs is limited because of drug resistance....